These CT antigens are potential cancer-associated biomarkers, which also play an immunogenic role in tumor-specific cytotoxic T cell response and humoral immune responses as demonstrated by MAGEA4 and SPAG1 [61, 62]. The gene discussed is SPAG1; the disease is cancer.